These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22617775)

  • 1. A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.
    Wang H; Pei W; Luan Q; Ma F; Zhou S; Zhao Z; Meng X; Zhang X; Liang X; Chen Y; Zhan Q; Lin C; Qian H; Zhao P
    Cancer Biol Ther; 2012 Jul; 13(9):712-9. PubMed ID: 22617775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.
    Chen Y; Qian H; Wang H; Zhang X; Fu M; Liang X; Ma Y; Zhan Q; Lin C; Xiang Y
    Gynecol Oncol; 2007 Dec; 107(3):505-12. PubMed ID: 17884151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
    Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
    J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ad-PUMA sensitizes ovarian cancer cells to chemotherapeutic agents.
    Luan QC; Sun YR; Han P; Chen Y
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4525-32. PubMed ID: 26698248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of pancreatic cancer targeting the K-Ras oncogene.
    Lisiansky V; Naumov I; Shapira S; Kazanov D; Starr A; Arber N; Kraus S
    Cancer Gene Ther; 2012 Dec; 19(12):862-9. PubMed ID: 23099885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
    Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
    Zhang QA; Yang XH; Chen D; Yan X; Jing FC; Liu HQ; Zhang R
    Cancer Biomark; 2018; 21(4):755-762. PubMed ID: 29355113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
    Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
    J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation.
    Yu J; Yue W; Wu B; Zhang L
    Clin Cancer Res; 2006 May; 12(9):2928-36. PubMed ID: 16675590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
    Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
    Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine.
    Li Y; Singh B; Ali N; Sarkar FH
    Int J Mol Med; 1999 Jun; 3(6):647-53. PubMed ID: 10341297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
    Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs.
    Wang H; Qian H; Yu J; Zhang X; Zhang L; Fu M; Liang X; Zhan Q; Lin C
    Cancer Biol Ther; 2006 Apr; 5(4):380-5. PubMed ID: 16481741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.
    Leitner S; Sweeney K; Oberg D; Davies D; Miranda E; Lemoine NR; Halldén G
    Clin Cancer Res; 2009 Mar; 15(5):1730-40. PubMed ID: 19223497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy.
    Hill R; Rabb M; Madureira PA; Clements D; Gujar SA; Waisman DM; Giacomantonio CA; Lee PW
    Cell Death Dis; 2013 Sep; 4(9):e791. PubMed ID: 24008735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.
    Gayral M; Lulka H; Hanoun N; Biollay C; Sèlves J; Vignolle-Vidoni A; Berthommé H; Trempat P; Epstein AL; Buscail L; Béjot JL; Cordelier P
    Hum Gene Ther; 2015 Feb; 26(2):104-13. PubMed ID: 25423447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.